These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 21969553)

  • 21. Association between the dysbindin gene (DTNBP1) and cognitive functions in Japanese subjects.
    Hashimoto R; Noguchi H; Hori H; Ohi K; Yasuda Y; Takeda M; Kunugi H
    Psychiatry Clin Neurosci; 2009 Aug; 63(4):550-6. PubMed ID: 19496996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The sandy (sdy) mouse: a dysbindin-1 mutant relevant to schizophrenia research.
    Talbot K
    Prog Brain Res; 2009; 179():87-94. PubMed ID: 20302821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reinvestigation of the dysbindin subunit of BLOC-1 (biogenesis of lysosome-related organelles complex-1) as a dystrobrevin-binding protein.
    Nazarian R; Starcevic M; Spencer MJ; Dell'Angelica EC
    Biochem J; 2006 May; 395(3):587-98. PubMed ID: 16448387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Proteome of BLOC-1 Genetic Defects Identifies the Arp2/3 Actin Polymerization Complex to Function Downstream of the Schizophrenia Susceptibility Factor Dysbindin at the Synapse.
    Gokhale A; Hartwig C; Freeman AH; Das R; Zlatic SA; Vistein R; Burch A; Carrot G; Lewis AF; Nelms S; Dickman DK; Puthenveedu MA; Cox DN; Faundez V
    J Neurosci; 2016 Dec; 36(49):12393-12411. PubMed ID: 27927957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deletion of Dtnbp1 in mice impairs threat memory consolidation and is associated with enhanced inhibitory drive in the amygdala.
    Huang CCY; Muszynski KJ; Bolshakov VY; Balu DT
    Transl Psychiatry; 2019 Apr; 9(1):132. PubMed ID: 30967545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlated alterations in serotonergic and dopaminergic modulations at the hippocampal mossy fiber synapse in mice lacking dysbindin.
    Kobayashi K; Umeda-Yano S; Yamamori H; Takeda M; Suzuki H; Hashimoto R
    PLoS One; 2011 Mar; 6(3):e18113. PubMed ID: 21448290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MeCP2 regulates the synaptic expression of a Dysbindin-BLOC-1 network component in mouse brain and human induced pluripotent stem cell-derived neurons.
    Larimore J; Ryder PV; Kim KY; Ambrose LA; Chapleau C; Calfa G; Gross C; Bassell GJ; Pozzo-Miller L; Smith Y; Talbot K; Park IH; Faundez V
    PLoS One; 2013; 8(6):e65069. PubMed ID: 23750231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of HapMap tag-SNPs in dysbindin (DTNBP1) reveals evidence of consistent association with schizophrenia.
    Voisey J; Swagell CD; Hughes IP; Lawford BR; Young RM; Morris CP
    Eur Psychiatry; 2010 Oct; 25(6):314-9. PubMed ID: 20615671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dysbindin deficiency in sandy mice causes reduction of snapin and displays behaviors related to schizophrenia.
    Feng YQ; Zhou ZY; He X; Wang H; Guo XL; Hao CJ; Guo Y; Zhen XC; Li W
    Schizophr Res; 2008 Dec; 106(2-3):218-28. PubMed ID: 18774265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence that the BLOC-1 protein dysbindin modulates dopamine D2 receptor internalization and signaling but not D1 internalization.
    Iizuka Y; Sei Y; Weinberger DR; Straub RE
    J Neurosci; 2007 Nov; 27(45):12390-5. PubMed ID: 17989303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. No evidence for association of the dysbindin gene [DTNBP1] with schizophrenia in an Irish population-based study.
    Morris DW; McGhee KA; Schwaiger S; Scully P; Quinn J; Meagher D; Waddington JL; Gill M; Corvin AP
    Schizophr Res; 2003 Apr; 60(2-3):167-72. PubMed ID: 12591580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dysbindin-containing complexes and their proposed functions in brain: from zero to (too) many in a decade.
    Ghiani CA; Dell'Angelica EC
    ASN Neuro; 2011 May; 3(2):. PubMed ID: 21504412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The DTNBP1 (dysbindin) gene contributes to schizophrenia, depending on family history of the disease.
    Van Den Bogaert A; Schumacher J; Schulze TG; Otte AC; Ohlraun S; Kovalenko S; Becker T; Freudenberg J; Jönsson EG; Mattila-Evenden M; Sedvall GC; Czerski PM; Kapelski P; Hauser J; Maier W; Rietschel M; Propping P; Nöthen MM; Cichon S
    Am J Hum Genet; 2003 Dec; 73(6):1438-43. PubMed ID: 14618545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DTNBP1 is associated with imaging phenotypes in schizophrenia.
    Narr KL; Szeszko PR; Lencz T; Woods RP; Hamilton LS; Phillips O; Robinson D; Burdick KE; DeRosse P; Kucherlapati R; Thompson PM; Toga AW; Malhotra AK; Bilder RM
    Hum Brain Mapp; 2009 Nov; 30(11):3783-94. PubMed ID: 19449336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single point mutation on the gene encoding dysbindin results in recognition deficits.
    Chang EH; Fernando K; Yeung LWE; Barbari K; Chandon TS; Malhotra AK
    Genes Brain Behav; 2018 Jun; 17(5):e12449. PubMed ID: 29227583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia.
    Straub RE; Jiang Y; MacLean CJ; Ma Y; Webb BT; Myakishev MV; Harris-Kerr C; Wormley B; Sadek H; Kadambi B; Cesare AJ; Gibberman A; Wang X; O'Neill FA; Walsh D; Kendler KS
    Am J Hum Genet; 2002 Aug; 71(2):337-48. PubMed ID: 12098102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Risk genes for schizophrenia and neuronal plasticity: molecular target for antipsychotic discovery].
    Hashimoto R; Yasuda Y; Ohi K; Fukumoto M; Yamamori H; Takeda M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2010 Jun; 30(3):103-7. PubMed ID: 20666140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutations in the BLOC-1 subunits dysbindin and muted generate divergent and dosage-dependent phenotypes.
    Larimore J; Zlatic SA; Gokhale A; Tornieri K; Singleton KS; Mullin AP; Tang J; Talbot K; Faundez V
    J Biol Chem; 2014 May; 289(20):14291-300. PubMed ID: 24713699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. No association evidence between schizophrenia and dystrobrevin-binding protein 1 (DTNBP1) in Taiwanese families.
    Liu CM; Liu YL; Fann CS; Yang WC; Wu JY; Hung SI; Chen WJ; Chueh CM; Liu WM; Liu CC; Hsieh MH; Hwang TJ; Faraone SV; Tsuang MT; Hwu HG
    Schizophr Res; 2007 Jul; 93(1-3):391-8. PubMed ID: 17407805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dysbindin gene variability is associated with cognitive abnormalities in first-episode non-affective psychosis.
    Varela-Gomez N; Mata I; Perez-Iglesias R; Rodriguez-Sanchez JM; Ayesa R; Fatjo-Vilas M; Crespo-Facorro B
    Cogn Neuropsychiatry; 2015; 20(2):144-56. PubMed ID: 25530342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.